EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

TPS55 - Asthma 06

Sunday 15 Jun, 12:45 PM - 13:45 PM Glasgow, United Kingdom
Poster Zone Thematic Poster Session
A Case of Herpes Zoster Following the First Dose of Benralizumab
A step towards standardized Clinical Remission Criteria for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): insights from a real-life study
Association of PTGS2 rs689466 polymorphism with asthma susceptibility among asthmatic of West Bengal, India
Contribution of biotherapies in the reintroduction of NSAIDs in patients with moderate to severe asthma, hypersensitive to COX-1 inhibitor NSAIDs
Early Real-World Outcomes of Tezepelumab in Severe Asthma Patients Unresponsive to Prior Biologics
Impact of aspirin-induced bronchospasm on the in vitro Aspirin Hypersensitivity Diagnostic Index in the patients with Aspirin Exacerbated Respiratory Disease
In silico system pharmacology modeling provides insights into a mechanism for greater potency of TSLP/TSLPR pathway inhibition with verekitug, a novel antibody antagonist of TSLPR, as compared to tezepelumab
Investigating the Role of IL17 rs763780 Gene Polymorphism Associated with Asthma among Population of West Bengal, India
Lichen planus following dupilumab treatment in patients with severe asthma and nasal sinus polyposis
Lymphocyte profile and asthma control during the treatment with benralizumab in real life
PROMs Improvement Effects of Biologics in Chronic Rhinosinusitis with Nasal Polyps Patients: Real-life Experience
PTGDR2 Blood Expression as a Potential Biomarker for Predicting Super-Response to IL-5-Targeted Therapies in Severe Asthma
Postoperative Anti-IgE Therapy for Chronic Rhinosinusitis with Nasal Polyps and Asthma: Efficacy and Prognostic Factors
Real-World Dupilumab Effectiveness Through 18 Months in Patients with CRSwNP and Coexisting Asthma: Results from the Global AROMA Registry
Risk Factors and Biomarkers for COVID-19 and Allergic Diseases
Role of nasal cytology in patients with bronchial asthma
Suspected EGPA in a patient on Dupilumab treatment: confirmed diagnosis of sarcoidosis - case report

Speakers